drugset / Trial / NCT01636076
Efficacy and Safety of QMF149 vs. Salmeterol Xinafoate/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)
RandomizedParallel-groupDouble-blindTreatment
Summary
To compare the efficacy, safety and pharmacokinetics of QMF149 delivered via Concept1 to salmeterol xinafoate/fluticasone propionate delivered via Accuhaler in adult patients with COPD
Timeline
- Start
- 2012-11
- Primary completion
- 2013-09
- Completion
- 2013-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluticasone | Other / unclassified | 500 ug | — |
| Subject | Indacaterol | Other / unclassified | 150 ug | — |
| Subject | Mometasone | Other / unclassified | 160 ug | — |
| Comparator | Salmeterol | Other / unclassified | 50 ug | — |